ASX - By Stock
|
LMG |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
Rod_Valens
|
21 |
8.4K |
1 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
21
|
8.4K
|
1
|
|
ASX - By Stock
|
NHE |
Re:
Ann: Change of Director's Interest Notice
|
|
Rod_Valens
|
22 |
5.6K |
8 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
22
|
5.6K
|
8
|
|
ASX - By Stock
|
NHE |
Re:
Ann: Investor Presentation
|
|
Rod_Valens
|
35 |
10K |
1 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
35
|
10K
|
1
|
|
ASX - By Stock
|
NHE |
Re:
Ann: Investor Presentation
|
|
Rod_Valens
|
35 |
10K |
1 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
35
|
10K
|
1
|
|
ASX - By Stock
|
NHE |
Re:
Ann: Investor Presentation
|
|
Rod_Valens
|
35 |
10K |
3 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
35
|
10K
|
3
|
|
ASX - By Stock
|
NHE |
Re:
Ann: Investor Presentation
|
|
Rod_Valens
|
35 |
10K |
2 |
20/01/24 |
20/01/24 |
ASX - By Stock
|
35
|
10K
|
2
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
Rod_Valens
|
2.4K |
1.1M |
9 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
2.4K
|
1.1M
|
9
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
Rod_Valens
|
2.4K |
1.1M |
4 |
02/12/23 |
02/12/23 |
ASX - By Stock
|
2.4K
|
1.1M
|
4
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
Rod_Valens
|
2.4K |
1.1M |
0 |
02/12/23 |
02/12/23 |
ASX - By Stock
|
2.4K
|
1.1M
|
0
|
|
ASX - By Stock
|
LMG |
Re:
Ann: Change of Director's Interest Notice
|
|
Rod_Valens
|
5 |
1.6K |
12 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
5
|
1.6K
|
12
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Latest Imaging and Clinical Trial Insights
|
|
Rod_Valens
|
46 |
14K |
13 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
46
|
14K
|
13
|
|
ASX - By Stock
|
AYA |
Re:
moving time?
|
|
Rod_Valens
|
6 |
4.2K |
1 |
13/08/23 |
13/08/23 |
ASX - By Stock
|
6
|
4.2K
|
1
|
|
IPOs
|
|
Re:
Nico.lab Pre IPO
|
|
Rod_Valens
|
685 |
542K |
2 |
12/08/23 |
12/08/23 |
IPOs
|
685
|
542K
|
2
|
|
ASX - By Stock
|
AYA |
Re:
Ann: AYA Conducts Successful Q-Submission Meeting with FDA
|
|
Rod_Valens
|
2 |
1.5K |
1 |
09/06/23 |
09/06/23 |
ASX - By Stock
|
2
|
1.5K
|
1
|
|
ASX - By Stock
|
BUB |
Re:
Ann: Bubs Australia - Board Changes
|
|
Rod_Valens
|
34 |
25K |
4 |
06/05/23 |
06/05/23 |
ASX - By Stock
|
34
|
25K
|
4
|
|
ASX - By Stock
|
BUB |
Re:
Ann: Bubs Australia - Board Changes
|
|
Rod_Valens
|
34 |
25K |
8 |
05/05/23 |
05/05/23 |
ASX - By Stock
|
34
|
25K
|
8
|
|
ASX - By Stock
|
PHO |
Re:
Ann: Scoping Study Confirms Outstanding Economics for Chaketma
|
|
Rod_Valens
|
6 |
2.0K |
7 |
09/12/22 |
09/12/22 |
ASX - By Stock
|
6
|
2.0K
|
7
|
|
ASX - By Stock
|
AYA |
Re:
Ann: Chairman and Managing Director Addresses to AGM
|
|
Rod_Valens
|
13 |
7.9K |
3 |
25/11/22 |
25/11/22 |
ASX - By Stock
|
13
|
7.9K
|
3
|
|
ASX - By Stock
|
AYA |
Re:
Ann: Chairman and Managing Director Addresses to AGM
|
|
Rod_Valens
|
13 |
7.9K |
3 |
20/11/22 |
20/11/22 |
ASX - By Stock
|
13
|
7.9K
|
3
|
|
ASX - By Stock
|
PHO |
Re:
Ann: 90% conversion of inferred to indicated resources at GK
|
|
Rod_Valens
|
2 |
1.1K |
3 |
17/11/22 |
17/11/22 |
ASX - By Stock
|
2
|
1.1K
|
3
|
|
IPOs
|
|
Re:
Nico.lab Pre IPO
|
|
Rod_Valens
|
685 |
542K |
2 |
26/10/22 |
26/10/22 |
IPOs
|
685
|
542K
|
2
|
|
IPOs
|
|
Re:
Nico.lab Pre IPO
|
|
Rod_Valens
|
685 |
542K |
4 |
24/10/22 |
24/10/22 |
IPOs
|
685
|
542K
|
4
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
Rod_Valens
|
20 |
5.9K |
6 |
14/10/22 |
14/10/22 |
ASX - By Stock
|
20
|
5.9K
|
6
|
|
ASX - By Stock
|
4DS |
Re:
Ann: Trading Halt
|
|
Rod_Valens
|
412 |
140K |
17 |
12/08/22 |
12/08/22 |
ASX - By Stock
|
412
|
140K
|
17
|
|
ASX - By Stock
|
EMV |
Re:
Ann: EMVision Secures Strategic Agreement With Keysight
|
|
Rod_Valens
|
41 |
12K |
10 |
13/05/22 |
13/05/22 |
ASX - By Stock
|
41
|
12K
|
10
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Trading Halt
|
|
Rod_Valens
|
17 |
8.8K |
14 |
02/05/22 |
02/05/22 |
ASX - By Stock
|
17
|
8.8K
|
14
|
|
ASX - By Stock
|
4DS |
Re:
Ann: 4DS Technical Update
|
|
Rod_Valens
|
487 |
182K |
6 |
11/04/22 |
11/04/22 |
ASX - By Stock
|
487
|
182K
|
6
|
|
ASX - By Stock
|
MLS |
Re:
oppies
|
|
Rod_Valens
|
127 |
41K |
5 |
02/04/22 |
02/04/22 |
ASX - By Stock
|
127
|
41K
|
5
|
|
ASX - By Stock
|
PHO |
Re:
* Article
|
|
Rod_Valens
|
9 |
4.7K |
2 |
20/03/22 |
20/03/22 |
ASX - By Stock
|
9
|
4.7K
|
2
|
|
ASX - By Stock
|
PHO |
Re:
* Article
|
|
Rod_Valens
|
9 |
4.7K |
5 |
16/03/22 |
16/03/22 |
ASX - By Stock
|
9
|
4.7K
|
5
|
|
ASX - By Stock
|
PHO |
Re:
* Article
|
|
Rod_Valens
|
9 |
4.7K |
1 |
16/03/22 |
16/03/22 |
ASX - By Stock
|
9
|
4.7K
|
1
|
|
ASX - By Stock
|
PHO |
* Article
|
|
Rod_Valens
|
9 |
4.7K |
1 |
16/03/22 |
16/03/22 |
ASX - By Stock
|
9
|
4.7K
|
1
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Change of Director's Interest Notice
|
|
Rod_Valens
|
5 |
2.2K |
16 |
07/02/22 |
07/02/22 |
ASX - By Stock
|
5
|
2.2K
|
16
|
|
IPOs
|
|
Re:
Nico.lab Pre IPO
|
|
Rod_Valens
|
685 |
542K |
0 |
31/01/22 |
31/01/22 |
IPOs
|
685
|
542K
|
0
|
|
IPOs
|
|
Re:
Nico.lab Pre IPO
|
|
Rod_Valens
|
685 |
542K |
2 |
31/01/22 |
31/01/22 |
IPOs
|
685
|
542K
|
2
|
|
IPOs
|
|
Re:
Nico.lab Pre IPO
|
|
Rod_Valens
|
685 |
542K |
0 |
30/01/22 |
30/01/22 |
IPOs
|
685
|
542K
|
0
|
|
IPOs
|
|
Re:
Nico.lab Pre IPO
|
|
Rod_Valens
|
685 |
542K |
5 |
29/01/22 |
29/01/22 |
IPOs
|
685
|
542K
|
5
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2021and beyond
|
|
Rod_Valens
|
10K |
3.6M |
3 |
19/01/22 |
19/01/22 |
ASX - By Stock
|
10K
|
3.6M
|
3
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Change of Director's Interest Notice
|
|
Rod_Valens
|
9 |
3.4K |
11 |
11/01/22 |
11/01/22 |
ASX - By Stock
|
9
|
3.4K
|
11
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Advance QLD Industry Fellowship Win
|
|
Rod_Valens
|
6 |
1.8K |
19 |
24/11/21 |
24/11/21 |
ASX - By Stock
|
6
|
1.8K
|
19
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Rod_Valens
|
39 |
9.7K |
13 |
01/08/21 |
01/08/21 |
ASX - By Stock
|
39
|
9.7K
|
13
|
|
ASX - By Stock
|
ALA |
Re:
Ann: SUDA Placement Raises $3.65m
|
|
Rod_Valens
|
27 |
9.7K |
2 |
22/06/21 |
22/06/21 |
ASX - By Stock
|
27
|
9.7K
|
2
|
|
ASX - By Stock
|
ALA |
Re:
Ann: SUDA Licenses a Novel iNKT Cell Therapy Platform
|
|
Rod_Valens
|
35 |
12K |
1 |
20/06/21 |
20/06/21 |
ASX - By Stock
|
35
|
12K
|
1
|
|
ASX - By Stock
|
ALA |
Re:
Ann: Investor Presentation incorporating iNKT Cell Platform
|
|
Rod_Valens
|
8 |
3.0K |
3 |
18/06/21 |
18/06/21 |
ASX - By Stock
|
8
|
3.0K
|
3
|
|
ASX - By Stock
|
LIO |
Re:
Ann: Cleansing Statement
|
|
Rod_Valens
|
9 |
2.2K |
0 |
04/05/21 |
04/05/21 |
ASX - By Stock
|
9
|
2.2K
|
0
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Appendix 4C - quarterly
|
|
Rod_Valens
|
24 |
8.1K |
9 |
02/05/21 |
02/05/21 |
ASX - By Stock
|
24
|
8.1K
|
9
|
|
IPOs
|
|
Re:
Nico.lab Pre IPO
|
|
Rod_Valens
|
685 |
542K |
1 |
20/04/21 |
20/04/21 |
IPOs
|
685
|
542K
|
1
|
|
IPOs
|
|
Re:
Nico.lab Pre IPO
|
|
Rod_Valens
|
685 |
542K |
0 |
19/04/21 |
19/04/21 |
IPOs
|
685
|
542K
|
0
|
|
IPOs
|
|
Re:
Nico.lab Pre IPO
|
|
Rod_Valens
|
685 |
542K |
1 |
19/04/21 |
19/04/21 |
IPOs
|
685
|
542K
|
1
|
|
IPOs
|
|
Re:
Nico.lab Pre IPO
|
|
Rod_Valens
|
685 |
542K |
3 |
17/04/21 |
17/04/21 |
IPOs
|
685
|
542K
|
3
|
|